US Stock MarketDetailed Quotes
CEROW CERO THERAPEUTICS HOLDINGS INC C/WTS 13/02/29 (TO PUR COM)
- 0.006
- +0.001+19.61%
Close Oct 1 16:00 ET
0.009High0.006Low
0.009High0.006Low46.31KVolume0.008Open0.005Pre Close361.74Turnover0.00%Turnover Ratio--P/E (Static)0Shares0.24752wk High--P/B0Float Cap0.00452wk Low--Dividend TTM0Shs Float0.247Historical High--Div YieldTTM50.98%Amplitude0.004Historical Low0.007Avg Price1Lot Size
About CERO THERAPEUTICS HOLDINGS INC C/WTS 13/02/29 (TO PUR COM) Company
Phoenix Biotech Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.
Company Profile
SymbolCEROW
Company NameCERO THERAPEUTICS HOLDINGS INC C/WTS 13/02/29 (TO PUR COM)
Listing DateOct 6, 2021
Founded2021
CEOMr. Chris Ehrlich
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address2201 Broadway,Suite 705
CityOakland
ProvinceCalifornia
CountryUnited States of America
Zip Code94612
Phone1-215-731-9450
Websitehttps://www.cero.bio
Company Executives
- Name
- Position
- Salary
- Chris Ehrlich
- Interim Chairman of the Board and Chief Executive Officer
- --
- Charles Carter
- Chief Financial Officer and Principal Accounting Officer
- --
- Daniel Corey, M.D.
- Chief Technical Officer and Director
- 376.04K
- Brian G. Atwood
- Director
- --
- Kathleen D. Laporte
- Director
- --
- Michael Byrnes
- Director
- --
- Dr. Lindsey Rolfe, M.D.
- Independent Director
- --
- Robyn Rapaport
- Independent Director
- --